Farms.com Home   News

Hypor Collaborates in New Research to Identify the Genetic Basis of Disease Resilient Pigs

New research that investigates the genetic ability for pigs to respond to disease challenges in a natural environment is underway thanks to the collaboration of Hypor, PigGen Canada, and a team of researchers from the Universities of Alberta, Guelph, Saskatchewan, Iowa State and the Centre de Dévelopement du Porc du Québec (CDPQ).

“This is a unique approach in that it exposes pigs to multiple pathogens simultaneously,” saysHypor Senior Geneticist, Dr. Patrick Charagu. He explains that this research model is more informative  than research that tests the genetic response to only one or two pathogens.

“Pigs may respond differently to each pathogen,” he says. “We want to see how they respond to exposure to a variety of types of diseases.”

Unlike other research programs that challenge pigs with specific diseases via inoculation, the current research project exposes pigs to several pathogens in a natural environment, such as throughpig-to-pig  contact, the manure, general airborne exposure.

The goal for the three-year program is to try to understand if there is underlying genetic explanation to how pigs respond to disease challenges. Approximately 3,500 Large White by Landrace cross (F1) barrows are health challenged and followed from wean to finish. Information and data, suchas morbidity, mortality, growth and feed conversion, are collected from each of the pigs. Upon slaughter  carcass data is also recorded.

Each of the seven genetic companies that are members of PigGen Canada are supplying their pigs for the collaborative research project.

Right at the beginning, prior to entering the research facility, pigs are tested for their innateability to respond to a pathogen challenge (immune response). This information is then later compared  to each pig’s reaction to actual disease exposure once it enters the research facility.

The idea is that the research will help to identify, and if possible quantify, a pig’s ability to withstand a disease challenge — a pig’s ability to maintain a high level of performance under disease exposure. This is referred to as disease resilience or tolerance.

“Ideally, this will help us to breed pigs that will be able to keep on performing optimally (eg feed conversion and reproduction) even if they are on a disease-challenged farm,” Dr. Charagu says. “This would lower health costs and improve performance, and hence profitability, for the pork producer.”

At the end of the day pork producers want pigs on their farm that are going to make them a profit. And Hypor’s aim is to breed pigs that are profitable for the pork producer.

This research fits right in place with Hypor’s goal as a genetics company. Hypor’s, and indeed Hendrix Genetics’, ambition is to breed animals that are good at withstanding all challenges while performing at a high level.

Source: Hypro


Trending Video

Sowing Success: Dr. Gordon Spronk's Journey with Pipestone and the Future of Swine Health

Video: Sowing Success: Dr. Gordon Spronk's Journey with Pipestone and the Future of Swine Health

Welcome back to In Swine Versation. Get ready for an enlightening journey as we delve into the remarkable story of Dr. Gordon Spronk, a founding partner at Pipestone, in our latest episode of "Sowing Success." In this episode, we'll be exploring key questions that shed light on Pipestone's evolution and the future of swine health. Here's a glimpse of what to expect:

1. Exploring Pipestone's Foundations: We'll kick off by uncovering the early vision behind Pipestone and how it has shaped the landscape for new entrepreneurs entering the field. Dr. Spronk will share insights into the core principles that have guided Pipestone's journey and how they continue to drive success today.

2. Industry-Shaping Experiences: Moving on to Dr. Spronk's impactful tenure at the National Pork Board, we'll explore his contributions to sustainability, growth accomplishments, and his vision for the future of pork production. Expect to gain insights into how Dr. Spronk's experiences have influenced the industry and what he envisions for its future.

3. Global Excellence and Growth: With Pipestone ranking second in the latest World Mega Producers ranking, we'll delve into what these impressive numbers signify and how Pipestone continues to excel on a global scale. Dr. Spronk will share his perspectives on the key factors driving Pipestone's success and its strategy for continued growth and innovation.

4. Navigating Challenges: We'll address the hot topic of Prop 12 and its implications for the industry. Dr. Spronk will provide valuable insights into the challenges and implementation issues faced by Pipestone and how the company is navigating through this complex landscape.

5. Updates on Wholestone Plant: Dr. Spronk will provide updates on the latest developments at the Wholestone plant in South Dakota, offering insights into how this initiative aligns with Pipestone's broader goals and objectives.

6. Transformative Journey of Pipestone Management: Taking a trip down memory lane, we'll explore the transformative journey of Pipestone Management since its inception in 1988. Dr. Spronk will share insights into the growth and evolution of Pipestone Management, highlighting key milestones and lessons learned along the way.

7. Defining Swine Health Success: Finally, we'll delve into Dr. Spronk's definition of swine health and its pivotal role in the success of Pipestone Management. Expect to gain a deeper understanding of the importance of swine health and how it drives Pipestone's mission and values.

Overall, this episode promises to be a thought-provoking exploration of Pipestone's journey and the future of swine health. Tune in for an engaging conversation that's sure to leave you inspired and informed about what lies ahead in the world of pork production.